ACIP: Benefits of COVID-19 vaccines outweigh risks Today Morbidity and Mortality Weekly Report (MMWR) published a summary of the findings of the Advisory Committee on Immunization Practices (ACIP) on adverse events related to the three COVID-19 vaccines approved for emergency use in the United States, two-dose mRNA vaccines from Pfizer and Moderna, and a single shot adenovirus vaccine from Johnson & Johnson.Since this spring, ACIP has met three times to discuss associations between the vaccines and adverse events, including myocarditis after the mRNA vaccines, and Guillain-Barré syndrome (GBS) and thrombosis with thrombocytopenia syndrome (TTS) after the Johnson & Johnson vaccine.On July 22, ACIP met and concluded that the benefits of all